Product image of Bortezomib Reddy (Bortezomib) supplied by GNH India

Bortezomib Reddy

Active Ingredient:
Bortezomib
Origin:
EU

Bortezomib Reddy (Bortezomib)

Bortezomib Reddy is a pharmaceutical product used for intravenous or subcutaneous administration. It is primarily used in the management of certain types of cancer, offering a targeted approach to treatment.

Manufacturer / TM Owner

Reddy Holding Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bortezomib Reddy is generally used in the treatment of multiple myeloma and mantle cell lymphoma. This medication works by interfering with the growth of cancer cells, making it a valuable option for patients requiring targeted therapy. It is often considered when other treatments have proven ineffective or in combination with other drugs.

Side Effects

  • Common effects associated with Bortezomib Reddy may include fatigue, nausea, and peripheral neuropathy. Some individuals might experience diarrhea or low blood cell counts. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

  • Bortezomib Reddy should be handled with care, especially by those with pre-existing conditions such as liver or kidney disease. It is important to follow the prescribed administration route, whether intravenous or subcutaneous, to ensure safety and efficacy. Regular blood tests may be recommended to monitor for potential side effects.

Avoid Interactions

  • Bortezomib Reddy may interact with other medications, particularly those that affect the liver or immune system. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional, as it may exacerbate certain side effects.

Frequently Asked Questions

Bortezomib Reddy is primarily used in the treatment of multiple myeloma and mantle cell lymphoma.

Bortezomib Reddy can be administered either intravenously or subcutaneously, depending on the prescribed treatment plan.

Common side effects may include fatigue, nausea, peripheral neuropathy, diarrhea, and low blood cell counts.

Individuals with pre-existing liver or kidney disease should use Bortezomib Reddy with caution and under medical supervision.

Yes, Bortezomib Reddy may interact with medications that affect the liver or immune system, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT